Trials that use: ANCOVA
New to this method? Read the tutorial →
2,968 results
- ConstellationIndependent statistical analysis of BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Contact: Developing New Clinical Management Strategies: Complete Statistical AnalysisIndependent statistical analysis of Contact: Developing New Clinical Management Strategies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03812588).
- Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Monitoring in Pregnant Women Undergoing Betamethasone Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01165775).
- Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Monitoring System (CGM)-Informed Bolus Calculator Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04320069).
- Continuous Glucose Sensor Profiles in Non-Diabetic Subjects: Complete Statistical AnalysisIndependent statistical analysis of Continuous Glucose Sensor Profiles in Non-Diabetic Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00717977).
- Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.: Complete Statistical AnalysisIndependent statistical analysis of Continuous Wearable Monitor for the Detection and Release of Freezing of Gait.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CONTROLIndependent statistical analysis of Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00184548).
- Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: Complete Statistical AnalysisIndependent statistical analysis of Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Cooling Vest May Reduce Heat Stress During Surgery: Complete Statistical AnalysisIndependent statistical analysis of Cooling Vest May Reduce Heat Stress During Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04511208).
- COPDIndependent statistical analysis of COPD: Oral Nutrition Supplements vs. Energy- and Protein Dense in Between Meal Snacks.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- COPEIndependent statistical analysis of A Study To Evaluate Pregabalin In The Treatment Of Moderate To Severe Chronic Bone Pain Related To Metastatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: Complete Statistical AnalysisIndependent statistical analysis of CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00889265).
- Copper Histidine Therapy for Menkes Diseases: Complete Statistical AnalysisIndependent statistical analysis of Copper Histidine Therapy for Menkes Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00001262).
- CoQ10Independent statistical analysis of Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Corneal Nerves Function and Structure: Complete Statistical AnalysisIndependent statistical analysis of Corneal Nerves Function and Structure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04222660).
- Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear: Complete Statistical AnalysisIndependent statistical analysis of Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): Complete Statistical AnalysisIndependent statistical analysis of Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00353795).
- Cortical Contributions to Motor Sequence Learning: Complete Statistical AnalysisIndependent statistical analysis of Cortical Contributions to Motor Sequence Learning: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04138953).
- Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: Complete Statistical AnalysisIndependent statistical analysis of Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01227980).
- Cortisol Response to Moderate and Deep Sedation in Children: Complete Statistical AnalysisIndependent statistical analysis of Cortisol Response to Moderate and Deep Sedation in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01265966).
- COSMOS-MindIndependent statistical analysis of COcoa Supplement and Multivitamin Outcomes Study for the Mind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03035201).
- COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06547814).
- COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): Complete Statistical AnalysisIndependent statistical analysis of COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04595773).
- COVIDX_EVCDAOIndependent statistical analysis of Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity - Experts' Opinion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- COZIIndependent statistical analysis of CBT-I or Zolpidem/Trazodone for Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04468776).
- CP-690-550 Ointment For Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of CP-690-550 Ointment For Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01246583).
- CPAP to Treat Cognitive Dysfunction in MS: Complete Statistical AnalysisIndependent statistical analysis of CPAP to Treat Cognitive Dysfunction in MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02544373).
- CPCIndependent statistical analysis of Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CPEX-011Independent statistical analysis of Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.: Complete Statistical AnalysisIndependent statistical analysis of Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CRCIndependent statistical analysis of Optimal Dose of Combination of Rocuronium and Cisatracurium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02495038).
- Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders: Complete Statistical AnalysisIndependent statistical analysis of Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CREDO 2Complete statistical analysis of the phase 3 CREDO 2 trial evaluating two olokizumab dosing regimens versus placebo and adalimumab in patients with active rheumatoid arthritis receiving methotrexate.
- CREMIndependent statistical analysis of Cognitive Remediation to Improve Mobility in Sedentary Seniors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02567227).
- Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD: Complete Statistical AnalysisIndependent statistical analysis of Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD: primary endpoint results, effect estimate with…
- Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CSPOTIndependent statistical analysis of Conduction System Pacing Optimized Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04905290).
- CTRADIndependent statistical analysis of Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CTREPHIndependent statistical analysis of Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CTS-1027 in Interferon-Naive Hepatitis C Patients: Complete Statistical AnalysisIndependent statistical analysis of CTS-1027 in Interferon-Naive Hepatitis C Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00925990).
- CTSI Pilot: Improving Adherence to Diabetic Diet: Complete Statistical AnalysisIndependent statistical analysis of CTSI Pilot: Improving Adherence to Diabetic Diet: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04051008).
- CURBIndependent statistical analysis of Cocaine Use Reduction With Buprenorphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01402492).
- Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Curcumin for the Prevention of Radiation-induced Dermatitis in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Curing Atrial Fibrillation in Heart Failure: Complete Statistical AnalysisIndependent statistical analysis of Curing Atrial Fibrillation in Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00292162).
- Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools: Complete Statistical AnalysisIndependent statistical analysis of Curriculum Evaluation of a Novel Health and Wellness Program Within New York City Schools: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Customized Cortical Stimulation Therapy in the Rehabilitation of Stroke Patients: Complete Statistical AnalysisIndependent statistical analysis of Customized Cortical Stimulation Therapy in the Rehabilitation of Stroke Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02544503).
- CUTEXIndependent statistical analysis of Cold Urticaria Treatment With Xolair: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580592).
- CV_WIZARDIndependent statistical analysis of CV Wizard: Does a Clinical Decision Support Tool Improve CVD Risk Factor Control in Safety Net Clinics?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels: Complete Statistical AnalysisIndependent statistical analysis of Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01678313).